To assess the effectiveness and user satisfaction of electronic lab notebooks (ELNs) among scientists in biopharma R&D, CROs, clinical diagnostics, and pharmaceutical manufacturing in the US and Europe.
Key Findings:
Only 62% of respondents feel their ELN helps them work efficiently, indicating a significant barrier to productivity.
5% reported being able to analyze experimental results independently using their ELN, highlighting a critical shortfall in functionality.
65% have repeated experiments due to difficulties in finding or reusing prior results, which directly inflates R&D costs.
56% find their ELN overly complex and time-consuming, suggesting a need for improved usability.
71% struggle with configuring ELNs to new workflows, rising to 84% in pharmaceutical manufacturing, indicating a lack of adaptability.
51% spend excessive time on data import/export tasks, which detracts from valuable research time.
45% use public generative AI tools to assist their work despite risks, reflecting a reliance on external solutions.
Interpretation:
The findings indicate that current ELNs are inadequate for supporting scientific reasoning and analysis, leading to inefficiencies that inflate R&D costs.
Limitations:
The survey sample may not represent all scientists' experiences with ELNs, potentially skewing the results.
Focus on specific sectors may limit generalizability of results, necessitating further research across diverse fields.
Conclusion:
Next-generation ELNs must evolve from mere record-keeping to active analytical tools, incorporating features like data interpretation and user-friendly interfaces to meet the demands of modern research.
